Home01P • FRA
add
Medpace Holdings Inc
Previous close
€316.10
Day range
€315.40 - €327.90
Year range
€213.00 - €418.70
Market cap
11.05B USD
Avg Volume
8.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 528.10M | 14.59% |
Operating expense | 251.41M | 12.26% |
Net income | 88.35M | 44.68% |
Net profit margin | 16.73 | 26.26% |
Earnings per share | 2.76 | 41.81% |
EBITDA | 112.38M | 32.35% |
Effective tax rate | 20.03% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 510.89M | 1,205.37% |
Total assets | 1.92B | 36.47% |
Total liabilities | 1.16B | 13.84% |
Total equity | 763.60M | — |
Shares outstanding | 30.93M | — |
Price to book | 12.80 | — |
Return on assets | 14.15% | — |
Return on capital | 30.09% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 88.35M | 44.68% |
Cash from operations | 116.40M | 41.06% |
Cash from investing | -12.79M | -51.06% |
Cash from financing | 666.00K | 100.81% |
Net change in cash | 103.88M | 1,434.58% |
Free cash flow | 76.42M | 23.59% |
About
Medpace Holdings, Inc. is a global clinical research organization based in Cincinnati, Ohio, employing approximately 5,400 people. Medpace's mission statement is "to accelerate the global development of safe and effective medical therapeutics" through its high science and disciplined operating approach that leverages local, regulatory, and deep therapeutic expertise across all major areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective. Operating under a full-service model, Medpace provides a therapeutically focused, integrated, global approach to clinical development. The company also offers global central laboratory, imaging core laboratory, and bioanalytical laboratory services, as well as a Phase I unit located on its headquarters and clinical research campus in Cincinnati, Ohio.
The company started trading stock as a public firm in 2016. Wikipedia
Founded
1992
Headquarters
Website
Employees
5,800